BioLight Life Sciences Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was ILS 0.01 million. Net loss was ILS 1.77 million compared to net income of ILS 0.425 million a year ago.

Basic loss per share from continuing operations was ILS 0.38 compared to basic earnings per share from continuing operations of ILS 0.09 a year ago. Diluted loss per share from continuing operations was ILS 0.38 compared to diluted earnings per share from continuing operations of ILS 0.09 a year ago.